Preconditioning the human myocardium by simulated ischemia: Studies on the early and delayed protection

Cardiovascular Research

Volumn 45, Issue 2, 2000, Pages 339-350

  Ghosh, Sudip ^a   Standen, Nicholas B ^a   Galiñanes, Manuel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Ischemia; Preconditioning

Indexed keywords

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HEART INFARCTION PREVENTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TISSUE INJURY;

ANALYSIS OF VARIANCE; CELL DEATH; CREATINE KINASE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; RANDOM ALLOCATION; TIME FACTORS;

EID: 0033960061     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00353-3     Document Type: Article

References (37)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Walker D.M., Walker J.M., Pugsley W.B., et al. Preconditioning in isolated superfused human muscle. J Moll Cell Cardiol. 27:1995;1349-1357.
3. Cleveland J.C. Jr., Wollmering M.M., Meldrum D.R., et al. Ischemic preconditioning in human and rat ventricle. Am. J. Physiol. 271:1996;H1786-H1794.
4. Ikonomidis J.S., Tumiati L.C., Weisel R.D., et al. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia. Cardiovasc. Res. 28:1994;1285-1291.
5. Deutsch E., Berger M., Kussmaul W.G., et al. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, haemodynamic and metabolic features. Circulation. 82:1990;2044-2051.
6. Yellon D.M., Alkhulaifi A.M., Pugsley W.B. Preconditioning the human myocardium. Lancet. 342:1993;276-277.
7. Galiñanes M., Ghosh S., Zhang J.G. Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischemia and reperfusion in man. J. Moll. Cell. Cardiol. 31:(6):1999;A47. Abstract.
8. Miura T., Limura O. Infarct limitation by preconditioning: its phenomenological features and key role of adenosine. Cardiovasc Res. 27:1993;36-42.
9. Van Winkle D.M., Thornton J.D., Downey D.M., Downey J.M. The natural history of preconditioning: cardioprotection depends of duration of transient ischemia and time to subsequent ischemia. Coronary Artery Dis. 2:1991;613-619.
10. Baxter G.F., Goma G.F., Yellon D.M. Characterization of the infarct-limiting effect of delayed preconditioning: time course and dose-dependency studies in rabbit myocardium. Basic Res. Cardiol. 92:1997;159-167.
11. Goto M., Liu Y., Yang X.-M., et al. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 77:1995;611-621.
12. Strasser R., Arras M., Vogt A., et al. Preconditioning of porcine myocardium: how much ischemia is required for induction? What is its duration? Is a renewal effect possible? Circulation. 909:(Suppl 1):1994;109. Abstract.
13. + channel blocker. Circulation. 90:1994;700-705.
14. Depouy P., Geschwind H., Pelle G., et al. Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans. J Am Coll Cardiol. 27:1996;1374-1380.
15. Schulz R., Post H., Valhaus C., et al. Ischemic preconditioning in pigs: a graded phenomenon. Its relation to adenosine and bradykinin. Circulation. 98:1998;1022-1029.
16. Sandhu R., Diaz R.J., Mao G.D., Wilson G.J. Ischemic preconditioning: difference in protection and susceptibility to blockade with single versus multicycle transient ischemia. Circulation. 96:1997;984-995.
17. Van Winckle D.M., Thornton J., Downey D.M., Downey J.M. The natural history of preconditioning: cardioprotection depends on duration on duration of transient ischemia and time to subsequent ischemia. Coronary Art Dis. 2:1991;613-619.
18. Cohen M.V., Yang X.-M., Downey J.M. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res. 74:1994;998-1004.
19. ATP channels. Circulation. 89:1994;1229-1236.
20. Miura T., Adachi T., Ogawa T., et al. Myocardial infarct-size limiting effect of ischemic preconditioning: its natural decay and the effect of repetitive preconditioning. Cardiovasc Pathol. 1:1992;147-154.
21. Murry C.E., Richard V.J., Jennings R.B., Reimer K.A. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am. J. Physiol. 260:1991;H796-H804.
22. Li Y., Kloner R.A. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am. J. Physiol. 268:1995;H426-H431.
23. ATP channels and ischemic preconditioning in dogs. Am. J. Physiol. 264:1993;H1327-H1336.
24. Schulz R., Rose J., Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol. 267:1994;H1341-H1352.
25. Schultz J.E.L., Rose E., Yao Z., Gross G.J. Evidence for the involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. 268:1995;H2157-H2161.
26. Cohen G., Shirai T., Weisel R.D., et al. Optimal myocardial preconditioning in a human model of ischemia and reperfusion. Circulation. 98:1998;184-196.
27. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 h after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 88:1993;1264-1272.
28. Kuzuya T., Hoshida S., Yamashita N., et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 72:1993;1293-1299.
29. Yang X.-M., Baxter G.F., Heads R.J., et al. Infarct limitation in the second window of protection in a conscious rabbit model. Cardivasc. Res. 31:1996;777-783.
30. Tanaka M., Fujiwara H., Yamasaki K., et al. Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 h or 48 h later in rabbit hearts. Am. J. Physiol. 267:1994;H1476-H1482.
31. Qian Y.Z., Bernado N.L., Nayeem M.A., et al. Induction of 72-kDa heat shock protein does not produce a second window of ischemic preconditioning in rat heart. Am. J. Physiol. 276:1999;H224-H234.
32. Baxter G.F., Goma F.M., Yellon D.M. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischemia in rabbit myocardium. Br. J. Pharmacol. 115:1995;222-224.
33. Baxter G.F., Mocanu M., Yellon D.M. Diacylglycerol treatment in vivo increases ischemic tolerance 24 h later in a rabbit model of myocardial infarction. J. Moll. Cell. Cardiol. 28:1996;A19.
34. Yamashita N., Nishida M., Hoshida S. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 h after preconditioning. J. Clin. Invest. 94:1994;2193-2199.
35. Yellon D.M., Marber M.S. Hsp 70 in myocardial ischemia. Experimentia. 50:1994;1075-1084.
36. Parratt J.R., Szekeres L. Delayed protection of the heart against ischemia. Trends Pharmacol. Sci. 16:1995;351-355.
37. ATP channels. Circ Res. 84:1999;846-851.